Federal contract award
75N95021F00003
DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | HHSN271201700020I |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.0M |
| Current contract value | $2.0M |
| Potential contract value / ceiling | $2.0M |
| Start date | Sep 24, 2021 |
| Current end date | Apr 29, 2025 |
| Potential end date | Apr 29, 2025 |
| Latest award activity | Apr 29, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 29, 2025 | P00005 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY |
| Jul 20, 2023 | P00004 | $5.6K | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY |
| Jun 23, 2023 | P00003 | $0 | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY |
| Aug 19, 2022 | P00002 | $19.0K | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY |
| Mar 31, 2022 | P00001 | $82.8K | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY |
| Sep 24, 2021 | 0 | $1.9M | DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAY |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.